To achieve $1 per share, ADO would need around $50M royalties pa (~$35M NPAT) using a conservative PE of 30. That figure is achievable (imo) given that both BBI & POC1 have been mentioned to worth "in excess of $10M pa" each. A few more signings with mid-size IVD/LSR companies that can generate ~$5M pa royalty (e.g. Luminex/Schott/Sony DADC - all speculations) and $50M is not out of the question. It can only grow from there with others to follow & bioseparations etc.
The most important aspect right now is to get the first major deal signed & income rolling in.
It's hard to find another bio stock in this end of town with such clear income trajectory & great management.
just imo
ceo headed to europe, page-178
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $40.20K | 1.786M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 386453 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 248196 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |